Observed arrival · 2026-09-16
AVL’s ¥56,000 HPV Vaccine Offer
Credibility concern recorded. The source reference remains available for verification and correction.
A Chinese-language service page offers a three-injection therapeutic nucleic acid vaccine program for existing HPV infections.
Field notes
The page outlines a three-dose schedule on days 0, 21, and 42, followed by a first check three months after the final injection. It names six eligible HPV types and quotes ¥56,000 for a single-type course, excluding testing. The site attributes its evidence to a researcher-initiated study of 20 patients, while acknowledging that the denominator and subtype breakdown are unclear. A nine-month non-clearance condition is presented as a hospital refund arrangement, not as a treatment guarantee.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue